Berenice Cabrera-Martinez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Berenice Cabrera-Martinez has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Ansgar Schulz
Department of Pediatrics, University Medical Center, Ulm, Germany
1 shared publication - Atanu Acharya
Syracuse University
1 shared publication - Doris Niewolik
Institute for Transfusion Medicine, University of Ulm 11 , Ulm, Germany
1 shared publication - Elena Wen-Yuan Hsieh
Department of Pediatrics & Internal Medicine, Division of Allergy and Immunology, UT Southwestern Medical Center, Dallas, USA
1 shared publication - Eva-Maria Jacobsen
Department of Pediatrics and Adolescent Medicine Ulm University Medical Center Ulm Germany
1 shared publication - Frederike A. Hartl
R&D Department, BioCopy GmbH, Emmendingen, Germany
1 shared publication
Latest Publications
- Open Access
- 14 November 2023
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 221 (1)
A partial human LCK defect causes a T cell immunodeficiency with intestinal inflammation
Lymphocyte-specific protein tyrosine kinase (LCK) is essential for T cell antigen receptor (TCR)–mediated signal transduction. Here, we report two siblings homozygous for a novel LCK variant (c.1318C>T; P440S) characterized by T cell lymphopenia with skewed memory phenotype, infant-onset recurrent infections, failure to thrive, and protracted diarrhea. The patients’ T cells show residual TCR signal transduction and proliferation following anti-CD3/CD28 and phytohemagglutinin (PHA) stimulation. We demonstrate in mouse models that complete (Lck−/−) versus partial (LckP440S/P440S) loss-of-function LCK causes disease with differing phenotypes. While both Lck−/− and LckP440S/P440S mice exhibit arrested thymic T cell development and profound T cell lymphopenia, only LckP440S/P440S mice show residual T cell proliferation, cytokine production, and intestinal inflammation. Furthermore, the intestinal disease in the LckP440S/P440S mice is prevented by CD4+ T cell depletion or regulatory T cell transfer. These findings demonstrate that P440S LCK spares sufficient T cell function to allow the maturation of some conventional T cells but not regulatory T cells—leading to intestinal inflammation.
- 14 November 2023
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 221 (1)
Open AccessA partial human LCK defect causes a T cell immunodeficiency with intestinal inflammation
Lymphocyte-specific protein tyrosine kinase (LCK) is essential for T cell antigen receptor (TCR)–mediated signal transduction. Here, we report two siblings homozygous for a novel LCK variant (c.1318C>T; P440S) characterized by T cell lymphopenia with skewed memory phenotype, infant-onset recurrent infections, failure to thrive, and protracted diarrhea. The patients’ T cells show residual TCR signal transduction and proliferation following anti-CD3/CD28 and phytohemagglutinin (PHA) stimulation. We demonstrate in mouse models that complete (Lck−/−) versus partial (LckP440S/P440S) loss-of-function LCK causes disease with differing phenotypes. While both Lck−/− and LckP440S/P440S mice exhibit arrested thymic T cell development and profound T cell lymphopenia, only LckP440S/P440S mice show residual T cell proliferation, cytokine production, and intestinal inflammation. Furthermore, the intestinal disease in the LckP440S/P440S mice is prevented by CD4+ T cell depletion or regulatory T cell transfer. These findings demonstrate that P440S LCK spares sufficient T cell function to allow the maturation of some conventional T cells but not regulatory T cells—leading to intestinal inflammation.